|
PDS5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.06049646631368E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.99325058867362E-12 |
| Normal-vs-Stage2 |
1.13700000003991E-06 |
| Normal-vs-Stage3 |
6.00460000055314E-07 |
| Normal-vs-Stage4 |
1.36380000004266E-06 |
| Stage1-vs-Stage2 |
7.729600E-01 |
| Stage1-vs-Stage3 |
4.771400E-01 |
| Stage1-vs-Stage4 |
8.131200E-01 |
| Stage2-vs-Stage3 |
7.671600E-01 |
| Stage2-vs-Stage4 |
6.535200E-01 |
| Stage3-vs-Stage4 |
4.677400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88189464012112E-11 |
| Normal-vs-AfricanAmerican |
7.3236000042165E-08 |
| Normal-vs-Asian |
1.85064000000068E-05 |
| Caucasian-vs-AfricanAmerican |
4.768800E-01 |
| Caucasian-vs-Asian |
4.956800E-01 |
| AfricanAmerican-vs-Asian |
3.575400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62736490949555E-12 |
| Normal-vs-Female |
5.70359999999548E-05 |
| Male-vs-Female |
1.759670E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.21180004603639E-09 |
| Normal-vs-Extreme_Weight |
6.84285961227715E-12 |
| Normal-vs-Obese |
4.75950000522474E-08 |
| Normal-vs-Extreme_Obese |
1.19870000037103E-07 |
| Normal_Weight-vs-Extreme_Weight |
7.180600E-01 |
| Normal_Weight-vs-Obese |
1.880400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.966600E-01 |
| Extreme_Weight-vs-Obese |
6.145900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.571200E-01 |
| Obese-vs-Extreme_Obese |
1.154250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.55710000004916E-06 |
| Normal-vs-Age(41-60Yrs) |
1.35990000371677E-08 |
| Normal-vs-Age(61-80Yrs) |
8.53761505936745E-14 |
| Normal-vs-Age(81-100Yrs) |
8.6988000136401E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.386400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.318400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.301030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.816500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.620100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.785400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.70041758451589E-12 |
| Normal-VS-Type2 PRCC |
8.35698177326094E-12 |
| Normal-VS-KIRP CIMP |
9.66310000000137E-05 |
| Normal-VS-Unclassified PRCC |
5.428900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.182600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.722600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.905600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.104400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.625500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.623600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55431223447522E-15 |
| Normal-vs-N1 |
6.610900E-04 |
| Normal-vs-N2 |
2.788700E-04 |
| N0-vs-N1 |
9.681300E-03 |
| N0-vs-N2 |
8.021200E-01 |
| N1-vs-N2 |
1.911840E-01 |
|
|
